Literature DB >> 17359287

Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression.

Etsu Tashiro1, Ayako Tsuchiya, Masaya Imoto.   

Abstract

Cyclin D1 binds to the Cdk4 and Cdk6 to form a pRB kinase. Upon phosphorylation, pRB loses its repressive activity for the E2F transcription factor, which then activates transcription of several genes required for the transition from the G1- to S-phase and for DNA replication. The cyclin D1 gene is rearranged and overexpressed in centrocytic lymphomas and parathyroid tumors and it is amplified and/or overexpressed in a major fraction of human tumors of various types of cancer. Ectopic overexpression of cyclin D1 in fibroblast cultures shortens the G1 phase of the cell cycle. Furthermore, it has been demonstrated that introduction of an antisense cyclin D1 into a human carcinoma cell line, in which the cyclin D1 gene is amplified and overexpressed, causes reversion of the malignant phenotype. Thus, increased expression of cyclin D1 can play a critical role in tumor development and in maintenance of the malignant phenotype. However, it is insufficient to confer transformed properties on primary or established fibroblasts. In this review, we summarize the role of cyclin D1 on tumor development and malignant transformation. In addition, our chemical biology study to understand the regulatory mechanism of cyclin D1 transcription is also reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359287     DOI: 10.1111/j.1349-7006.2007.00449.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  101 in total

1.  Downregulation of tNASP inhibits proliferation through regulating cell cycle-related proteins and inactive ERK/MAPK signal pathway in renal cell carcinoma cells.

Authors:  Jianzheng Fang; Hainan Wang; Wei Xi; Gong Cheng; Shangqian Wang; Shifeng Su; Shengli Zhang; Yunfei Deng; Zhen Song; Aiming Xu; Bianjiang Liu; Jingyi Cao; Zengjun Wang
Journal:  Tumour Biol       Date:  2015-02-12

2.  Perspectives of gene combinations in phenotype presentation.

Authors:  Shihori Tanabe
Journal:  World J Stem Cells       Date:  2013-07-26       Impact factor: 5.326

3.  Regulation of cyclin D1 RNA stability by SNIP1.

Authors:  Cameron P Bracken; Steven J Wall; Benjamin Barré; Kostya I Panov; Paul M Ajuh; Neil D Perkins
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

4.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 5.  Potential roles of longan flower and seed extracts for anti-cancer.

Authors:  Chih-Cheng Lin; Yuan-Chiang Chung; Chih-Ping Hsu
Journal:  World J Exp Med       Date:  2012-08-20

6.  Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independence.

Authors:  Wen-Bin Ou; Nan Ni; Rui Zuo; Weihao Zhuang; Meijun Zhu; Anastasios Kyriazoglou; Duolin Wu; Grant Eilers; George D Demetri; Haibo Qiu; Bin Li; Adrian Marino-Enriquez; Jonathan A Fletcher
Journal:  Oncogene       Date:  2019-08-01       Impact factor: 9.867

7.  Bmi-1-shRNA inhibits the proliferation of lung adenocarcinoma cells by blocking the G1/S phase through decreasing cyclin D1 and increasing p21/p27 levels.

Authors:  Xiangyu Zheng; Yifang Wang; Ben Liu; Chunqing Liu; Dandan Liu; Jie Zhu; Chunhui Yang; Jiangzhou Yan; Xiaobo Liao; Xiuxiang Meng; Hong Yang
Journal:  Nucleic Acid Ther       Date:  2014-02-19       Impact factor: 5.486

8.  MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1.

Authors:  Zhijun Ma; Yulan Ma; Qinghua Xia; Yong Li; Ruidong Li; Weilong Chang; Jinhuang Chen; Zhengwei Leng; Kaixiong Tao
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-08       Impact factor: 4.553

9.  Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 4 (vIRF4) Perturbs the G1-S Cell Cycle Progression via Deregulation of the cyclin D1 Gene.

Authors:  Hye-Ra Lee; Jaba Mitra; Stacy Lee; Shou-Jiang Gao; Tae-Kwang Oh; Myung Hee Kim; Taekjip Ha; Jae U Jung
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

10.  Expression of Cyclin D1 Is Associated with β-Catenin Expression and Correlates with Good Prognosis in Colorectal Adenocarcinoma.

Authors:  Kyu Yun Jang; Yo Na Kim; Jun Sang Bae; Myoung Ja Chung; Woo Sung Moon; Myoung Jae Kang; Dong Geun Lee; Ho Sung Park
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.